ORCL Buys Relsys – Zacks Tale of the Tape
Source: http://www.zacks.com/stock/news/18445/ORCL+Buys+Relsys+-+Zacks+Tale+of+the+TapePosted on Monday, March 23rd, 2009 | In Stocks to Watch
Oracle (ORCL) declared today that it is buying Relsys International, a drug safety and risk management software provider.
With the acquisition, Oracle expects to create a portfolio of software applications that support drug safety processes across clinical development, post-market surveillance and patient care.
The Redwood City-based software company also said Relsys will “bring significant domain knowledge and experience” to Oracle’s health sciences global business unit.
The Relsys acquisition deal is expected to close in the first half of 2009. However, the terms of the deal were not revealed.
The company, which has been in an acquisition spree of late, had agreed to buy mValent on Feb 4, 2009. On Nov 3 in 2008, Oracle had acquired the intellectual property assets of Tacit Software.
ORCL is a Zacks #3 Rank (”Hold”) company.
“ORCL” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- TV to Launch Wireless Service - Analyst Blog - November 23rd, 2009
- Motorola Boosts iDEN Business - Analyst Blog - November 23rd, 2009
- Marathon to Slash Spending - Analyst Blog - November 23rd, 2009
- XL Expands in China - Analyst Blog - November 23rd, 2009
- Novellus Raises Guidance - Analyst Blog - November 23rd, 2009
mValent;, Oracle, ORCL;, Redwood City, Relsys - Zacks Tale;, Relsys International;, risk management software;, software, software applications, Stocks to Watch, Tacit Software;, Zacks Market Commentaries
![]() About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |




